Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia
暂无分享,去创建一个
A. Österborg | J. Lundin | M. Brytting | H. Mellstedt | E. Rossmann | A. Linde | H. Dahl | C. Karlsson